Linshom Medical CEO, Ric Hughen, joins Rich Bendis on BioTalk to discuss his career, their respiratory monitor, and growing a company in the BioHealth Capital Region.
Richard Hughen’s thirty years of medical device experience spans three Fortune 500 and three start-up companies with two successful exits to date. He is currently CEO of Linshom Medical, a start-up that is first to deliver continuous predictive respiratory monitoring (CPRM) to the patient bedside and home.
Ric was an investor and member of the executive team that built the start-up CSA Medical from a technology license (U.S. Navy) through product development, animal trials, clinical trials, five FDA clearances, CE mark, three rounds of funding ($50M), commercial growth, and a 2019 sale to Steris. In addition, Ric was Managing Director of LearnWare, a life science focused e-learning start-up, which was successfully built and sold to a private equity fund. He is currently a reviewer for the National Science Foundation’s SBIR/STTR program, an Entrepreneur in Residence for Johns Hopkins Tech Ventures, an advisory board member of George Mason University’s Bioengineering Alliance and a site miner for TEDCO at the University of Maryland Medical Center in Baltimore.
Ric’s background crosses diverse clinical fronts including respiratory sensors, interventional pulmonology, thoracic surgery, interventional cardiology, gastroenterology, ENT, oncology, orthopedics, gynecology, wound care, molecular diagnostics, imaging and health-IT.
He is the founder of Life Science Planning, a strategic consultancy for life science companies with a focus on fast-paced start-ups, early-stage, and emerging growth companies. Earlier in his career, Ric led various senior management, marketing, training and sales teams for Johnson & Johnson, BD, Abbott, and Cordis. Ric holds MBA and BS degrees from The Pennsylvania State University. When not working, he is typically outside training for a triathlon competition.